{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:39:41Z","timestamp":1788698381904,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00277-024-05933-3","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T10:17:46Z","timestamp":1724408266000},"page":"4345-4347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy"],"prefix":"10.1007","volume":"103","author":[{"given":"Vanda","family":"Strafella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Attolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Carluccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Curci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Sgherza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ostuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Buda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Livia","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Margiotta-Casaluci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana Beatrice","family":"Valli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candida Rosaria","family":"Germano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria","family":"Quinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano Arangio","family":"Febbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ciuffreda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Reddiconto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Di Renzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cimminiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"8","key":"5933_CR1","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3324\/haematol.2020.261842.PMID","volume":"106","author":"C Hulin","year":"2021","unstructured":"Hulin C, Offner F, Moreau P, Roussel M, Belhadj K, Benboubker L, Caillot D, Facon T, Garderet L, Kuhnowski F, Stoppa AM, Kolb B, Tiab M, Jie KS, Westerman M, Lambert J, Pei L, Vanquickelberghe V, De Boer C, Vermeulen J, Kampfenkel T, Sonneveld P, Van de Donk NWCJ (2021) Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab\u2009+\u2009bortezomib\/thalidomide\/dexamethasone in the phase 3 CASSIOPEIA study. Haematologica 106(8):2257\u20132260. https:\/\/doi.org\/10.3324\/haematol.2020.261842.PMID","journal-title":"Haematologica"},{"issue":"5","key":"5933_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000529691","volume":"50","author":"S Sauer","year":"2023","unstructured":"Sauer S, Kriegsmann K, Nientiedt C, Schmitt A, M\u00fcller-Tidow C, Raab MS, Kauer J (2023) Autologous stem cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in newly diagnosed multiple myeloma. Transfus Med Hemother 50(5):371\u2013381. https:\/\/doi.org\/10.1159\/000529691PMID: 37936633; PMCID: PMC10626396","journal-title":"Transfus Med Hemother"},{"issue":"13","key":"5933_CR3","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1080\/10428194.2023.2253479","volume":"64","author":"E Eleutherakis Papaiakovou","year":"2023","unstructured":"Eleutherakis Papaiakovou E, Terpos E, Kanellias N, Migkou M, Gavriatopoulou M, Ntanasis-Stathopoulos I, Fotiou D, Malandrakis P, Theodorakakou F, Spiliopoulou V, Kostopoulos IV, Tsitsiloni O, Tsirigotis P, Dimopoulos MA, Kastritis E (2023) Impact of daratumumab on stem cell mobilization and collection, engraftment and early post-transplant complications among multiple myeloma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 64(13):2140\u20132147 Epub 2023 Sep 1. PMID:37655597","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"5933_CR4","doi-asserted-by":"crossref","first-page":"340e","DOI":"10.1016\/j.jtct.2023.02.013","volume":"29","author":"A Thurlapati","year":"2023","unstructured":"Thurlapati A, Roubal K, Davis JA, Shah SZ, Smith D, McGann M, Gaffney K, Cendagorta A, Maldonado A, Weeda E, Hashmi H (2023) Stem cell mobilization for multiple myeloma patients receiving daratumumab-based induction therapy: a real- world experience. Transpl Cell Ther 29(5):340e. 1-340.e4Epub 2023 Feb 19. PMID: 36804934","journal-title":"Transpl Cell Ther"},{"key":"5933_CR5","doi-asserted-by":"publisher","unstructured":"Fazio F, Passucci M, Micozzi J, Di Landro F, Fianchi L, Za T, Manieri VM, Annibali O, Cupelli L, Bongarzoni V, Gentili S, De Padua L, Crisanti E, Garzia MG, Rago A, Piciocchi A, Mengarelli A, Mor\u00e8 S, De Stefano V, Bafti MS, Martelli M, Petrucci MT (2024 Mar) Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the multiple Myeloma Group. Bone Marrow Transpl 9. https:\/\/doi.org\/10.1038\/s41409-024-02260-zOnline ahead of print. PMID: 38461292","DOI":"10.1038\/s41409-024-02260-z"},{"key":"5933_CR6","doi-asserted-by":"publisher","unstructured":"Zappaterra A, Civettini I, Cafro AM, Pezzetti L, Pierini S, Anghilieri M, Bellio L, Bertazzoni P, Grillo G, Minga P, Pioltelli ML, Ravano E, Sassone M, Vigan\u00f2 CV, Volpato EB, Gambacorti-Passerini C, Rossini S, Cairoli R, Crocchiolo R Anti-CD38 monoclonal antibody impairs CD34\u2009+\u2009mobilization and affects clonogenic potential in multiple myeloma patients. Blood Transfus 2024 Jan 24. https:\/\/doi.org\/10.2450\/BloodTransfus.667. Epub ahead of print. PMID: 38315530.","DOI":"10.2450\/BloodTransfus.667"},{"key":"5933_CR7","doi-asserted-by":"publisher","unstructured":"Duan H, Jiang Q, Liu L, Deng M, Lai Q, Jiang Y, Li Z, Xu B, Lin Z Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma. Ann Hematol. 2024 Mar 6. https:\/\/doi.org\/10.1007\/s00277-024-05683-2. Epub ahead of print. PMID: 38448787","DOI":"10.1007\/s00277-024-05683-2"},{"issue":"3","key":"5933_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/bmt.2011.82","volume":"47","author":"A Olivieri","year":"2012","unstructured":"Olivieri A, Marchetti M, Lemoli R, Tarella C, Iacone A, Lanza F, Rambaldi A, Bosi A (2012) Italian Group for Stem Cell Transplantation. Proposed definition of \u2018poor mobilizer\u2019 in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo. ItalianoTrapianto Di Midollo Osseo Bone Marrow Transpl 47(3):342\u2013351. https:\/\/doi.org\/10.1038\/bmt.2011.82Epub 2011 May 30","journal-title":"ItalianoTrapianto Di Midollo Osseo Bone Marrow Transpl"},{"key":"5933_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-018-0119-4","volume":"7","author":"X Ma","year":"2018","unstructured":"Ma X, Wong SW, Zhou P, Chaulagain CP, Doshi P, Klein AK, Sprague K, Kugelmass A, Toskic D, Warner M, Miller KB, Lee L, Varga C (2018) Comenzo RL Daratumumab binds to mobilized CD34\u2009+\u2009cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth. Exp Hematol Oncol 7:27. https:\/\/doi.org\/10.1186\/s40164-018-0119-4PMID: 30356940; PMCID: PMC6192105","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"5933_CR10","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/bjh.19141","volume":"204","author":"O Venglar","year":"2024","unstructured":"Venglar O, Kapustova V, Anilkumar Sithara A, Zihala D, Muronova L, Sevcikov T, Vrana J, Vdovin A, Radocha J, Krhovska P, Hrdinka M, Turjap M, Popkova T, Chyra Z, Broskevicova L, Simicek M, Koristek Z, Hajek R, Jelinek T (2024) Insight into the mechanism of CD34\u2009+\u2009cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy. Br J Haematol 204(4):1439\u20131449. https:\/\/doi.org\/10.1111\/bjh.19141Epub 2023 Oct 9. PMID: 37807708","journal-title":"Br J Haematol"},{"issue":"2","key":"5933_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/ejh.14008","volume":"111","author":"A Seth","year":"2023","unstructured":"Seth A, Murray D, Buadi FK, Gertz MA, Yadav U, Kumar SK, Gonsalves WI (2023) Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody. Eur J Haematol 111(2):318\u2013321. https:\/\/doi.org\/10.1111\/ejh.14008Epub 2023 May 20. PMID: 37209032; PMCID: PMC10524502","journal-title":"Eur J Haematol"},{"issue":"3","key":"5933_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jtct.2022.11.029","volume":"29","author":"S Chhabra","year":"2023","unstructured":"Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardso PG, Voorhees PM (2023) Stem cell mobilization yields with Daratumumab- and lenalidomide-containing quadruplet induction therapy in newly diagnosed multiple myeloma: findings from the MASTER and GRIFFIN trials. Transpl Cell Ther 29(3):174. https:\/\/doi.org\/10.1016\/j.jtct.2022.11.029Epub 2022 Dec 6. PMID: 36494017","journal-title":"Transpl Cell Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05933-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05933-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05933-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:54:10Z","timestamp":1732679650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05933-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["5933"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05933-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the ethical committee of the coordinating center (AOUC Policlinico di Bari) and the local committees of the participating centers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}